Rep. Diana DeGette (D-Colo.) is a possible candidate to succeed retiring Rep. Anna Eshoo (D-Calif.) as the ranking Democrat or chair of the House E&C Health Subcommittee.
Who will succeed retiring Rep. Anna Eshoo (D-Calif.) as top Democrat on the House Energy & Commerce (E&C) subcommittee that [...] …
The White House plans to release a revised administrative dispute resolution process for the 340B program this month.
The federal 340B program remains on track to publish a final rule this month revising its administrative dispute resolution (ADR) [...] …
In response to the ongoing Change Healthcare cyberattack, CMS will direct contractors to provide some accelerated payments to hospitals.
Critical access hospitals (CAHs) and Ryan White HIV/AIDS clinics do not expect problems implementing a new requirement starting Jan. 1, [...] …
The parties involved in a legal challenge over certain Medicaid managed care drug benefits have jointly asked for a pause in proceedings.
Both sides in a lawsuit over New York state’s transfer of Medicaid managed care drug benefits to Medicaid fee for [...] …
A JAMA Health Network literature review found that the 340B program provides a range of benefits but needs reforms.
The 340B program has provided a range of benefits but also needs reforms, according to a recent review of published [...] …
A JAMA Health Forum study co- authored by Sean Dickson found the 340B program's footprint in Medicare Part D is increasing.
340B covered entities captured nearly half (49.9%) of their 340B-eligible prescriptions billed to Medicare Part D in 2020, up from [...] …
Two drugmakers, Mallinckrodt's subsidiary SpecGx and Novo Nordisk, owe refunds to 340B providers for certain overcharges.
Two drugmakers will offer refunds to 340B providers for overcharges in recent years. Drug manufacturer Mallinckrodt’s SpecGx generic pharmaceutical subsidiary [...] …
AHF has asked a federal appeals court to reverse an earlier court's decision to dismiss a case against Apexus over its provision of 340B sub-ceiling price discounts on drugs.
Apexus, the 340B prime vendor, asked a federal appeals court to affirm a lower court’s dismissal of claims that it [...] …
The White House plans to release a revised administrative dispute resolution process for the 340B program this month.
Hospital groups will meet with federal executive branch officials to discuss coming changes to the 340B program’s administrative dispute resolution [...] …
The hospital Insight Chicago and federal regulators have agreed to dismiss a case before a federal district court over the hospital's 340B eligibility.
A federal district judge in Illinois has dismissed a Chicago hospital’s apparently successful lawsuit challenging its termination from the 340B [...] …
*Sign up for news summaries and alerts from 340B Report
Copyright © 2025 340B Report, LLC
Reproduction of material from any 340B Report page without written permission is strictly prohibited.
